Cancer stem cells (CSCs) are a small but critical cell population for cancer biology since they display 21 
A modification. (b) Sphere forming assay. siRNA-transfected cells were seeded at low density (1 cell/µL) in non-adherent conditions and serum-deprived medium. This type of suspension culture allows the survival and growth of stemlike/progenitor cells. Following 7 days of culture, the number of spheres correlates with the initial number of CSC. (c) FTO silencing increases the sphere forming potential of CRC1 cell line. Colonosphere formation was quantified following knockdown of the main m 6 A actors. Results are expressed in fold change compared to si-CTL. n = 3 biological replicates. Mean +/-S.E.M, ** p-value < 0.01. Two-sided Unpaired T-test. (d) FTO silencing increases the sphere forming potential in four CRC cell lines. Colonospheres quantification after silencing of FTO by two distinct siRNA, in four cell lines derived from primary tumors or metastasis. Results are expressed in fold change compared to si-CTL (n = 3 biological replicates). Mean +/-S.E.M, * p-value < 0.05 ; ** p-value < 0.01. Two-sided Unpaired T-test. (e-g) Expression of CSC biomarkers. Level of ALDH activity (e) as well as cellsurface expression of CD44 (f) and CD44v6 (g) were evaluated by flow cytometry in CRC1-sh-FTO cell line vs sh-CTL. Graphs show one representative biological replicate (n = 3). Bar plots show quantification of the number of ALDH (e), CD44 and CD44v6 positive cells from three biological replicates. Mean +/-S.E.M, *p-value < 0.05, **p-value < 0.01. Two-sided Unpaired T-test. (f) In vivo tumor initiation assay. Either 1,000, 500 or 100 CRC1 sh-FTO / sh-CTL cells were subcutaneously injected into nude mice. After 7 weeks, the number of tumorbearing mice (tumor > 100 mm 0.1µM SN38). As expected, 0.2 X FIRI treatment triggered cell cycle arrest at G2/M phase and increased 128 subG1 cells ( Figure S2b) . Surviving cells demonstrated increased ALDH activity ( Figure S2c) and 129 enhanced resistance to chemotherapy ( Figure S2d) . While variations of METTL3 and ALKBH5 levels 130 could be noticed following chemoresistance acquisition, they were not consistent between cell lines 131 (Figure 2d ). By contrast, FTO level was decreased by half in both cell lines (Figure 2d) . Noteworthy, the 132 correlation between FTO mRNA expression levels and protein abundance varies from one cell line to 133 another ( Figure S2e) . 134
Together, these findings demonstrate that FTO expression is tightly linked to the CSC chemoresistant 135 phenotype. 136 A/A after PCIF1 silencing in CTC44 line. Graphs represent mean +/-S.E.M of 3 biological replicates. *p-value < 0.05, ns = not significant. Two-Sided Unpaired T-test. (g) PCIF1 silencing "rescues" sphere forming ability in CRC1 sh-FTO cell line. PCIF1 was depleted by siRNA treatment in sh-FTO cell line and sphere formation assay was performed. Results are mean +/-S.E.M of three independent experiments. *p-value < 0.05, ns = not significant. One-way Anova followed by multiple comparisons.
Recent reports identified PCIF1/CAPAM as the m 6 Am methyltransferase ("writer") [28, 42] (Figure 4d ) 176 and proposed that PCIF1/CAPAM activity is involved in cellular resistance to oxidative stress response 177 induction [28] . It is well known that elevated reactive oxygen species (ROS) production impairs self-178 renewal and promote cell differentiation in stem cells and their malignant counterpart [43] . To 179 examine the contribution of PCIF1/CAPAM to CSC phenotype, we silenced PCIF1 in two CTC lines 180
( Figure S4b ) and tested both SFP and resistance to chemotherapy. As expected, PCIF1/CAPAM 181 knockdown reduced sphere number by 30% (Figure 4e control of certain mRNAs [28] . Consistent with the lack of effect of FTO modulation on proliferation 226 (Figure S1e) , polysome fractionation profile did not reveal significant changes in global translation 227 activity, which would be expected to modify the ratio between unassembled ribosome subunits, 228 monosome and polysome size and numbers (Figure 6b) . 229
We therefore performed RNA-seq on mRNA co-sedimenting with heavy polysomes (4+ ribosomes 230 /mRNA) or light polysomes/monosomes (1-3 ribosomes per mRNA). We mapped reads to the human 231 reference transcriptome to determine mRNAs that were differentially translated between sh-CTL and 232 sh-FTO cell lines. The volcano plots of the light and heavy analyses (Figure 6c) show stronger changes 233 in translation than in transcription (Figure 6a) . Globally, 23 mRNAs were differentially translated in the 234 heavy fraction, and 26 in the light fraction (|log2(FC)|>2 and (-log10(p-value)> 1.5), including ribosome 235 related proteins (RPL13A, RPS7, FXR1, UTP4, or NOP10) ( Table S5 and A m marked transcripts (identified by Wei J et al. [41] ) in total mRNA and significantly regulated transcripts (sh-FTO CRC1 cell line, FDR < 0.05). Pvalues were obtained using Fisher exact test. Nevertheless, while we see modest but significant differences at the translation level, we cannot 333 exclude the involvement of other mechanism(s). 334
In summary, we have shown that cytoplasmic FTO activity regulates m 6 Am modification of selected 335 mRNAs and subtly but surely is necessary for maintaining the CSC phenotype in vitro and in vivo for 336 human colon cancers. The extent to which this applies to other cancers remains to be determined: 337
given the complexity of cancer, there will likely be a great variability between cancer types. Even if 338 limited to colon cancer, however, our findings point the way to deeper understanding of the CSC 339 phenotype and have exciting implications for developing therapies that decrease m 6 Am modification 340 to cripple CSC-based metastases and resistance. 341
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